Suchergebnisse - "1474-0338" OR "1744-764X"

PubPharm (4.938)

3501

Drug safety and efficacy evaluation of sertindole for schizophrenia

enthalten in: Expert opinion on drug safety | 2012

von Karamatskos, E. | Lambert, M. | Mulert, C. | +1

3502

Drug safety evaluation of dronedarone in atrial fibrillation

enthalten in: Expert opinion on drug safety | 2012

von De Ferrari, G. | Dusi, V.

3503

Statins : safety and pharmacological interactions

enthalten in: Expert opinion on drug safety | 2012

von Di Girolamo, G. | González, C.

3504

Statin drug interactions and related adverse reactions

enthalten in: Expert opinion on drug safety | 2012

von Bellosta, S. | Corsini, A.

3505

Are salt loading and prolonging infusion period effective in prevention of amphotericin B-induced nephrotoxicity?

enthalten in: Expert opinion on drug safety | 2012

von Karimzadeh, I. | Farsaei, S. | Khalili, H. | +1

3506

Not everything about atrial fibrillation is a hot topic : drug-induced atrial fibrillation is an exception

enthalten in: Expert opinion on drug safety | 2012

von Bai, R.

CommentOn: Expert Opin Drug Saf. 2012 Jul;11(4):615-34. - PMID 22724662

3507

A drug safety evaluation of everolimus in kidney transplantation

enthalten in: Expert opinion on drug safety | 2012

von Holdaas, H. | Midtvedt, K. | Åsberg, A.

3508

Related articles

enthalten in: Expert opinion on drug safety | 2012

3509

Not everything about atrial fibrillation is a hot topic: drug-induced atrial fibrillation is an exception

enthalten in: Expert opinion on drug safety | 2012

von Bai, R.

3510

Safety of erythropoiesis-stimulating agents in patients with end-stage kidney disease: data are safer than extrapolations

enthalten in: Expert opinion on drug safety | 2012

von Abraham, I. | MacDonald, K.